ArticleHGG advances2026
Deciphering the genetic underlying causes of sex differences in multiple myeloma incidence and mortality.
Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Multiple myeloma (MM) is a genetically complex cancer that has a higher incidence and mortality in males when compared to females. These sex differences are well documented epidemiologically, yet their biological mechanisms remain uncharacterized. We hypothesized that sex-specific genetic regulation by somatic mutations affects MM cell gene expression differently in each sex and subsequently leads to differential functional genetic dependencies between the two sexes. To test this, we first identified genes with sex-biased expression in MM, then identified sex-specific somatic regulators of these genes, evaluated their association with overall survival outcomes, and finally assessed their functional importance using CRISPR-Cas9 dependency screens in MM cell lines. Our findings provide systematic evidence that sex-differentiated somatic regulation underlies tumor-intrinsic mechanisms in MM, establishing the importance of incorporating sex-aware molecular analyses for improved biomarker discovery and precision medicine. Collectively, these results establish sex as a fundamental biological variable in MM with significant implications for disease outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.